ProSciento is a leading specialty clinical research organization (CRO) exclusively focused on NASH, diabetes, obesity and related metabolic diseases. Building on nearly two decades of experience and more than 350 metabolic clinical projects conducted, ProSciento provides customized clinical research services for multinational, early development clinical trial programs designed to give our clients an advantage in today’s rapidly evolving landscape of metabolic drug and device development.

Our Uncompromising Commitment to Science, Patients and Our Team:

What drives us to excel each day is our unwavering commitment to science-driven contributions to research; a focus on the patients that may benefit from the clinical research programs we conduct; and our team of talented employees passionate about the development of life-changing therapeutics.